Rebate Rule Implementation Date Would Bring Chaos to Medicare Part D Program January 26, 2021 (Washington, D.C.) The Pharmaceutical Care Management Association (PCMA) has filed a motion for summary judgment to vacate the effective date of the Trump Administration’s rebate rule. The motion for summary judgment, filed in the U.S. District Court for the District of Columbia, seeks to vacate the January 1, 2022 effective date for the rebate rule with respect to Part D. The motion is vitally important to ensuring the stability of the Medicare Part D program as the Biden Administration reviews the Trump Administration’s “midnight regulations” and PCMA proceeds with litigation to revoke the rule in its entirety.
Predictions For How Telehealth Law Will Evolve In 2021 By
Nathaniel Lacktman Law360 is providing free access to its coronavirus coverage to make sure all members of the legal community have accurate information in this time of uncertainty and change. Use the form below to sign up for any of our weekly newsletters. Signing up for any of our section newsletters will opt you in to the weekly Coronavirus briefing.
Sign up for our Cybersecurity & Privacy newsletter
You must correct or enter the following before you can sign up:
Email (NOTE: Free email domains not supported)
Primary area of interest Law360 (January 21, 2021, 5:48 PM EST)
The Federal Bureau of Investigation (FBI), Department of Health and Human Services Office of Inspector General (HHS-OIG), and Centers for Medicare & Medicaid Services (CMS) are warning the public about several emerging fraud schemes related to COVID-19 vaccines.
The Situation: The adoption of new technologies has been a hallmark of the health care industry in the twenty-first century. While these technologies have helped to improve both.